Cargando…
Correction to: A cross‑section observational study on the seroprevalence of antibodies to COVID‑19 in patients receiving opiate agonist treatment
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390020/ https://www.ncbi.nlm.nih.gov/pubmed/34436756 http://dx.doi.org/10.1007/s11845-021-02742-9 |
| _version_ | 1783743001247350784 |
|---|---|
| author | Fenton, Fiona Stokes, Siobhan Eagleton, Marie |
| author_facet | Fenton, Fiona Stokes, Siobhan Eagleton, Marie |
| author_sort | Fenton, Fiona |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8390020 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83900202021-08-27 Correction to: A cross‑section observational study on the seroprevalence of antibodies to COVID‑19 in patients receiving opiate agonist treatment Fenton, Fiona Stokes, Siobhan Eagleton, Marie Ir J Med Sci Correction Springer International Publishing 2021-08-26 2022 /pmc/articles/PMC8390020/ /pubmed/34436756 http://dx.doi.org/10.1007/s11845-021-02742-9 Text en © Royal Academy of Medicine in Ireland 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Correction Fenton, Fiona Stokes, Siobhan Eagleton, Marie Correction to: A cross‑section observational study on the seroprevalence of antibodies to COVID‑19 in patients receiving opiate agonist treatment |
| title | Correction to: A cross‑section observational study on the seroprevalence of antibodies to COVID‑19 in patients receiving opiate agonist treatment |
| title_full | Correction to: A cross‑section observational study on the seroprevalence of antibodies to COVID‑19 in patients receiving opiate agonist treatment |
| title_fullStr | Correction to: A cross‑section observational study on the seroprevalence of antibodies to COVID‑19 in patients receiving opiate agonist treatment |
| title_full_unstemmed | Correction to: A cross‑section observational study on the seroprevalence of antibodies to COVID‑19 in patients receiving opiate agonist treatment |
| title_short | Correction to: A cross‑section observational study on the seroprevalence of antibodies to COVID‑19 in patients receiving opiate agonist treatment |
| title_sort | correction to: a cross‑section observational study on the seroprevalence of antibodies to covid‑19 in patients receiving opiate agonist treatment |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390020/ https://www.ncbi.nlm.nih.gov/pubmed/34436756 http://dx.doi.org/10.1007/s11845-021-02742-9 |
| work_keys_str_mv | AT fentonfiona correctiontoacrosssectionobservationalstudyontheseroprevalenceofantibodiestocovid19inpatientsreceivingopiateagonisttreatment AT stokessiobhan correctiontoacrosssectionobservationalstudyontheseroprevalenceofantibodiestocovid19inpatientsreceivingopiateagonisttreatment AT eagletonmarie correctiontoacrosssectionobservationalstudyontheseroprevalenceofantibodiestocovid19inpatientsreceivingopiateagonisttreatment |